[Form 4] Unusual Machines, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Andrew Camden, Chief Operating Officer of Unusual Machines, Inc. (UMAC), reported two planned sales of common stock under a Rule 10b5-1 plan to cover tax obligations from prior equity grants. On 08/20/2025 he sold 8,750 shares at a weighted-average price of $9.8005, reducing his direct ownership to 224,750 shares. On 08/21/2025 he sold 35,000 shares at a weighted-average price of $10.2075, reducing his direct ownership to 189,750 shares. The filer states the sales were executed by an independent third party and the original grants were exempt from Section 16(b) under Rule 16b-3. The filing is signed and dated 08/22/2025.

Positive

• Sales executed under a Rule 10b5-1 plan, indicating pre-scheduled, non-discretionary transactions
• Independent third party executed the sales, which supports the affirmative defense against insider trading claims
• Original grants were Board-approved and exempt from Section 16(b) under Rule 16b-3

Negative

• Insider selling of 43,750 shares over two days reduces the reporting person’s direct holding from 233,500 to 189,750 shares
• Weighted-average sale prices vary across multiple transactions, requiring the filer to offer further breakdowns upon request

Insights

Financial Analyst

TL;DR: Routine tax-motivated insider sales under a 10b5-1 plan; no new company operational disclosures.

The two transactions—8,750 shares sold 08/20/2025 at a weighted-average $9.8005 and 35,000 shares sold 08/21/2025 at a weighted-average $10.2075—appear to be mechanized disposals to satisfy income tax liabilities from prior equity grants. The reporting person retains 189,750 shares after the trades. These sales were executed pursuant to an independent 10b5-1 plan and the original grants were Board-approved and exempt under Rule 16b-3, which reduces immediate governance concerns. There is no additional financial or operational information in this Form 4 to assess company performance.

Corporate Governance Expert

TL;DR: Disclosure aligns with standard governance practice for planned insider sales; documentation offered for pricing details.

The filer explicitly documents that sales were made under a pre-established Rule 10b5-1 plan and executed by an independent third party, which supports an affirmative defense to insider trading claims. The explanation also notes that the stock sales were to cover tax obligations from prior, Board-approved grants exempt under Rule 16b-3. The reporting person offers to provide detailed pricing breakdowns on request, which enhances transparency. No departures from disclosure norms are evident in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Camden Andrew Ross

(Last) (First) (Middle)

4677 L B MCLEOD ROAD, SUITE J

(Street)

ORLANDO FL 32811

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Unusual Machines, Inc. [ UMAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	08/20/2025		S(2)		8,750	D	$9.8005(3)	224,750	D
Common Stock	08/21/2025		S(2)		35,000	D	$10.2075(4)	189,750	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold pursuant to a Rule 10b-5 plan under which the Reporting Person previously gave an independent third party the power to sell shares.

2. The shares were sold to permit the Reporting Person to pay income taxes arising from prior grants of common stock. All of the grants were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors.

3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $9.7999 to 9.805, inclusive. The reporting person undertakes to provide to Unusual Machines, Inc., any security holder of Unusual Machines, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence

4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $9.4798 to $10.5314, inclusive. The reporting person undertakes to provide to Unusual Machines, Inc., any security holder of Unusual Machines, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

	/s/ Andrew Camden	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Andrew Camden sell and when?

He sold 8,750 shares on 08/20/2025 and 35,000 shares on 08/21/2025 as reported on the Form 4.

At what prices were the shares sold?

Weighted-average prices: $9.8005 for the 08/20/2025 sales and $10.2075 for the 08/21/2025 sales; the filer notes multiple transactions within reported price ranges.

Why were the shares sold?

To pay income taxes arising from prior grants of common stock, and the sales were made pursuant to a Rule 10b5-1 plan.

How many shares does the reporting person own after the transactions?

189,750 shares (direct ownership) following the reported sales.

Does the filing indicate any wrongdoing or undisclosed company events?

No. The Form 4 discloses routine, planned sales and states grants were Board-approved and exempt under Rule 16b-3.